WiserTogether, Inc., a Washington, D.C.- and Boston, MA-based healthcare treatment comparison software company, completed a $9m Series B funding.
The round was led by Martin Ventures and Merck Global Health Innovation Fund (Merck GHI) with participation from CEO Shub Debgupta, and existing investors Grotech Ventures, Harbert Venture Partners, 7Wire Ventures and Blue Heron Capital.
The company intends to use the funds to scale its operations and expand its customer base across key sectors of healthcare.
Led by Debgupta, WiserTogether provides personalized healthcare comparison software that enables consumers to compare over 4,000 of the highest cost treatments using personal, financial and clinical factors and to engage with the right treatment.
Through their employers and health plans, the company serves over 3 million people.